Scarica l'app Stockscreener
14.33
0.07%
-0.010
Dopo l'orario di chiusura:
14.31
-0.02
-0.14%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$14.34
Aprire:
$14.3
Volume 24 ore:
3.55M
Relative Volume:
1.20
Capitalizzazione di mercato:
$2.86B
Reddito:
$3.90B
Utile/perdita netta:
$-413.00M
Rapporto P/E:
-6.9227
EPS:
-2.07
Flusso di cassa netto:
$365.00M
1 W Prestazione:
+0.49%
1M Prestazione:
-10.61%
6M Prestazione:
-16.44%
1 anno Prestazione:
-43.56%
Intervallo 1D:
$14.18
$14.51
Intervallo di 1 settimana:
$13.89
$14.71
Portata 52W:
$12.16
$27.48
Dentsply Sirona Inc Stock (XRAY) Company Profile
Nome
Dentsply Sirona Inc
Settore
Industria
Telefono
844-546-3722
Indirizzo
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Confronta XRAY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
14.33 | 2.86B | 3.90B | -413.00M | 365.00M | -2.07 |
|
ISRG
Intuitive Surgical Inc
|
471.15 | 170.01B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
195.40 | 55.63B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
281.96 | 41.75B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
81.36 | 40.27B | 9.93B | 1.12B | 1.43B | 2.26 |
|
WST
West Pharmaceutical Services Inc
|
245.97 | 17.58B | 2.96B | 487.70M | 344.00M | 6.68 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Downgrade | Needham | Buy → Hold |
| 2025-02-14 | Iniziato | Wells Fargo | Equal Weight |
| 2025-01-23 | Downgrade | Jefferies | Buy → Hold |
| 2025-01-07 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-11-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Reiterato | Needham | Buy |
| 2024-08-20 | Reiterato | Needham | Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-11-16 | Iniziato | Needham | Buy |
| 2023-11-10 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Aggiornamento | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Downgrade | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-04-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-04-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-01 | Ripresa | Credit Suisse | Outperform |
| 2021-08-09 | Reiterato | H.C. Wainwright | Neutral |
| 2021-08-06 | Reiterato | Barrington Research | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-03-02 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Reiterato | H.C. Wainwright | Neutral |
| 2021-01-05 | Reiterato | H.C. Wainwright | Neutral |
| 2020-12-18 | Downgrade | Stifel | Buy → Hold |
| 2020-11-17 | Downgrade | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Reiterato | H.C. Wainwright | Neutral |
| 2020-10-22 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-08-10 | Reiterato | H.C. Wainwright | Neutral |
| 2020-06-16 | Iniziato | Piper Sandler | Overweight |
| 2020-06-15 | Reiterato | H.C. Wainwright | Neutral |
| 2020-05-27 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Reiterato | H.C. Wainwright | Neutral |
| 2020-04-08 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Downgrade | Goldman | Buy → Neutral |
| 2020-04-02 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Reiterato | H.C. Wainwright | Neutral |
| 2020-02-19 | Reiterato | Stifel | Buy |
| 2019-12-11 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Aggiornamento | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Iniziato | Evercore ISI | In-line |
| 2019-07-09 | Reiterato | H.C. Wainwright | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Peer Perform |
Mostra tutto
Dentsply Sirona Inc Borsa (XRAY) Ultime notizie
Analyzing DENTSPLY SIRONA Inc. with risk reward ratio chartsTrade Risk Report & Low Risk High Reward Ideas - Newser
Dentsply Sirona : named one of the World’s Greenest Companies 2025 by Newsweek - MarketScreener
Applying sector rotation models to DENTSPLY SIRONA Inc.July 2025 Pullbacks & Low Drawdown Investment Strategies - Newser
How to use Fibonacci retracement on DENTSPLY SIRONA Inc.2025 Top Gainers & Scalable Portfolio Growth Methods - Newser
Dentsply Sirona ($XRAY) Is Paying a $84M Settlement to Investors — Here’s How to Get Your Share - TradingView
Smart tools for monitoring DENTSPLY SIRONA Inc.’s price actionWeekly Stock Recap & Low Drawdown Investment Ideas - Newser
Full technical analysis of DENTSPLY SIRONA Inc. stockMarket Volume Report & Accurate Intraday Trade Tips - Newser
DENTSPLY SIRONA Inc. stock trend outlook and recovery pathJuly 2025 Selloffs & Weekly Momentum Picks - Newser
Will DENTSPLY SIRONA Inc. stock recover after recent dropQuarterly Performance Summary & Accurate Trade Setup Notifications - Newser
Is it too late to sell DENTSPLY SIRONA Inc.Long Setup & Real-Time Volume Spike Alerts - Newser
Dentsply Sirona to Participate in Upcoming Investor Conferences - GlobeNewswire
Global Dental Solutions Leader Dentsply Sirona to Present at Morgan Stanley and Baird Healthcare Forums - Stock Titan
Custom strategy builders for tracking DENTSPLY SIRONA Inc.Weekly Volume Report & Free Reliable Trade Execution Plans - Newser
Is it time to cut losses on DENTSPLY SIRONA Inc.Treasury Yields & Smart Investment Allocation Insights - Newser
Technical analysis overview for DENTSPLY SIRONA Inc. stockJuly 2025 Sector Moves & Reliable Entry Point Alerts - Newser
Volume Profile Shows Strong Base for DENTSPLY SIRONA Inc.Weekly Risk Summary & Stock Portfolio Risk Management - beatles.ru
Combining machine learning predictions for DENTSPLY SIRONA Inc.Market Movement Recap & AI Forecasted Entry and Exit Points - Newser
Why DENTSPLY SIRONA Inc. is moving todayTrade Analysis Summary & Free High Return Stock Watch Alerts - Newser
What are DENTSPLY SIRONA Inc.’s recent SEC filings showingTrade Volume Report & Free Expert Verified Stock Movement Alerts - theviewers.co.kr
Sentiment analysis tools applied to DENTSPLY SIRONA Inc.Market Trend Report & Weekly High Conviction Trade Ideas - Newser
Key resistance and support levels for DENTSPLY SIRONA Inc.2025 Geopolitical Influence & Free Real-Time Volume Trigger Notifications - Newser
Candlestick Signal Suggests Reversal in DENTSPLY SIRONA Inc.July 2025 Chart Watch & Weekly Top Performers Watchlists - 더경남뉴스
Technical signs of recovery in DENTSPLY SIRONA Inc.July 2025 Outlook & Short-Term High Return Ideas - Newser
Does DENTSPLY SIRONA Inc. meet Warren Buffett’s criteria2025 Macro Impact & Verified Short-Term Trading Plans - theviewers.co.kr
Chart Analysts Warn of Resistance Near DENTSPLY SIRONA Inc. PriceWeekly Earnings Recap & Low Risk High Win Rate Picks - 더경남뉴스
DENTSPLY Stock Implied Volatility Suggests Big Move Ahead - AInvest
Is the Options Market Predicting a Spike in DENTSPLY Stock? - Yahoo Finance
Will DENTSPLY SIRONA’s (XRAY) Maintained Dividend and Sales Guidance Shift Recovery Expectations? - simplywall.st
Signal strength of DENTSPLY SIRONA Inc. stock in tech scannersJuly 2025 Gainers & Technical Pattern Based Buy Signals - Newser
Published on: 2025-08-19 14:31:12 - Newser
Is DENTSPLY SIRONA Inc. Forming a Consolidation BaseJuly 2025 Snapshot & Free Weekly Chart Analysis and Trade Guides - classian.co.kr
Dentsply Sirona: Turnaround Potential And Digital Workflows (NASDAQ:XRAY) - Seeking Alpha
SureSmile clear aligners—a proven system for predictably treating malocclusion - Dental Tribune US
Dentures Market Future Business Opportunities 2025-2032 | Dentsply Sirona Inc., Ivoclar Vivadent Ag, GC America Inc - openPR.com
Dentsply Sirona shares rise 2.53% premarket after announcing the availability of CEREC Tessera®. - AInvest
CEOs linked to $3M+ home purchases in Charlotte - The Business Journals
Dental CAD-CAM Market Forecast and Company Analysis Report 2025-2029, with 3Shape, Align Technology, Carestream Dental, Dentsply Sirona, Jensen Dental, Schutz Dental, and Yenadent - Yahoo Finance
Digital Dentistry Solutions Market 9.90% CAGR Analysis with - openPR.com
Will DENTSPLY SIRONA Inc. announce a stock splitJuly 2025 Volume & High Conviction Investment Ideas - thegnnews.com
Can DENTSPLY SIRONA Inc. disrupt its industryBuy Signal & Risk Managed Investment Strategies - thegnnews.com
Dentsply Sirona Settled $84M Over Anti-Competitive Practices – How to Claim Your Payout - TradingView
Dentsply Sirona : Sustainability Report 2024 Fifth year of continued progress, with several goals reached ahead of time - MarketScreener
Dental Implants and Prosthetics Company Evaluation Report 2025 | Institut Straumann, Envista, and Dentsply Sirona Lead with Innovation and Expansive Portfolios - Yahoo Finance
Dental Burs Market 2025 | Size, Trends, Innovations & Global - openPR.com
Mizuho lowers Dentsply Sirona stock price target on margin concerns By Investing.com - Investing.com Canada
Stocks Surge Amid Fed Interest Rate Speculation: Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Among Winners - AInvest
Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know - uk.finance.yahoo.com
Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know | FinancialContent - FinancialContent
Analysts’ Top Healthcare Picks: DENTSPLY SIRONA (XRAY), Replimune Group (REPL) - The Globe and Mail
Healthcare Analysts Offer Insights on Trevi Therapeutics, DENTSPLY SIRONA, and Arrowhead Pharmaceuticals. - AInvest
DENTSPLY SIRONA, Replimune Group, and Enovis Analysts Maintain Neutral Ratings - AInvest
Dentsply Sirona Inc Azioni (XRAY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.14%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):